Peptides
Last Updated
Jun 4, 2026
Table of contents
If you have followed peptide therapy over the last three years, you have watched the rules flip twice. As of mid-2026, a short list of peptides is legally accessible through licensed telehealth clinics working with 503A and 503B compounding pharmacies, and a much larger list is sitting one regulatory step away from coming back.
That second part is the whole story right now. Fourteen of the most-requested peptides, including BPC-157, CJC-1295, and TB-500, were moved out of the restricted category in April 2026 and are awaiting a formal FDA advisory review on July 23, 2026. Until that review and the guidance behind it land, no legitimate clinic can dispense them, no matter what its marketing says. So this guide does two things: it maps what is genuinely legal to get today, and it shows which clinics are actually positioned to carry the full list the moment the reopening completes.
The numbers
The crackdown, then the reversal.
How we got here
Three years, two reversals.
The whole regulatory saga, from the first restriction to the reopening that is still in progress.
The FDA begins moving popular peptides to Category 2 of its interim 503A bulk drug substances list, which effectively blocks licensed pharmacies from compounding them.
Nineteen peptides sit on the restricted list, including BPC-157, TB-500, CJC-1295, Ipamorelin, Thymosin Alpha-1, and AOD-9604. Patients lose their legitimate pathway almost overnight.
Enforcement widens. The FDA issues warning letters to research-chemical vendors, Lilly secures an import-blocking order on tirzepatide, and gray-market suppliers are raided or shut down.
The announcement. HHS signals that roughly fourteen of the nineteen restricted peptides will move back toward legal compounding, on the position that the FDA had been overly restrictive and was pushing patients toward the gray market.
The list updates. The FDA revises the 503A list, moving the fourteen out of Category 2 and into Category 1, under evaluation. This is progress, not a green light. Compounding does not resume yet.
Where it gets decided. A formal FDA advisory committee review is scheduled for the affected peptides. Until that review and the guidance behind it publish, expected through Q2 to Q3 2026, these peptides remain legally off the table. Some pharmacies are already taking pre-orders.
Methodology
How we scored.
This is a peptide-specific ranking. A clinic can be excellent overall and still land mid-pack here if its peptide menu is thin, because we are scoring peptide therapy specifically, not general hormone care. Every clinic was scored on five criteria, each worth two points, for a maximum of ten, with clinical depth and price transparency weighted most heavily.
Formulary relevance. How much of the genuinely legal list the clinic offers, and how ready it is for the reopening.
Clinical depth. Who writes the prescription, what bloodwork is required, how monitoring works.
Price and transparency. Published pricing, clarity on inclusions, how lab costs are handled.
Accessibility. State coverage, telehealth infrastructure, ease of getting started.
Reputation. Time in market, patient reviews, regulatory standing, pharmacy-partner records.
The rankings at a glance
Seven clinics, side by side.
| Rank | Clinic | Score | Coverage | Pricing | Best for |
|---|---|---|---|---|---|
| 1 | OneTwenty Full coverage + testing | 9.5 | National telehealth | $499/yr membership | Data-driven care |
| 2 | Defy Medical Broad practice | 9.1 | Tampa + national | $200 to $650/mo | Experienced patients |
| 3 | Marek Health Deepest data | 8.7 | National | $166+/mo plus labs | Optimization nerds |
| 4 | Victory Select Specialty menu | 8.0 | Regional (TX-based) | Quote on consult | Rare peptides |
| 5 | Maximus Sermorelin entry | 7.9 | All 50 states | $199/mo, labs included | Sermorelin first-timers |
| 6 | TRT Nation TRT first | 7.6 | National | $99/mo flat | TRT plus BPC-157 |
| 7 | Blue Sky MD In-person option | 6.8 | North Carolina | Quote on consult | NC residents |
Overall score
Ranked by total.
The formulary map
What is legal now, and who carries it.
Peptides down the side, clinics across the top. Filled dots are legal and available today. Coral rings are the peptides moved out of restriction in April 2026 that are still pending the July review, so the ring shows which clinics are positioned to carry them once the reopening completes, not what they can dispense this minute.
| Peptide | OneTwenty | Defy | Marek | Victory | Maximus | TRT Nation | Blue Sky |
|---|---|---|---|---|---|---|---|
Sermorelin Growth hormone · legal now | |||||||
Tesamorelin Growth hormone (FDA) · legal now | |||||||
PT-141 Sexual health (FDA) · legal now | |||||||
Gonadorelin Hormone (FDA) · legal now | |||||||
NAD+ Longevity · legal now | |||||||
Glutathione Antioxidant · legal now | |||||||
BPC-157 Recovery · pending July 2026 | |||||||
TB-500 Recovery · pending July 2026 | |||||||
CJC-1295 Growth hormone · pending July 2026 | |||||||
Ipamorelin Growth hormone · pending July 2026 | |||||||
Thymosin Alpha-1 Immune · pending July 2026 | |||||||
GHK-Cu Skin & tissue · pending July 2026 | |||||||
KPV Anti-inflammatory · pending July 2026 | |||||||
AOD-9604 Metabolic · pending July 2026 | |||||||
| Total coverage | 14 | 13 | 11 | 11 | 1 | 2 | 4 |
The honest read on this map: the legal-now list is short and most serious clinics share a similar core, so breadth alone is not the whole story. What separates the leaders is who covers the full legal-now core, who runs real testing behind the prescription, and who is genuinely positioned, through pharmacy relationships and pre-orders, to carry the returning peptides the day the July review clears them.
The real cost
What a year actually runs.
Estimated all-in annual cost of the core care program. Headline monthly fees hide a lot, so this folds in labs where a clinic charges separately.
OneTwenty’s $499 covers the membership layer: quarterly lab panels, wearable and device data, AI coaching, and telehealth visits. Compounded medications are billed at pharmacy cost on top. Even with meds added, the testing-and-care layer is the lowest in the category. Ranges for other clinics reflect base fee plus typical lab spend.
Featured reviews
The clinics, in depth.
OneTwenty
Every other clinic on this list sells you the peptide. OneTwenty sells you the full picture the peptide should be prescribed from. Membership is built on quarterly comprehensive blood panels, continuous data from your wearable, scale, and blood-pressure cuff, an AI coaching layer that reads all of it, and telehealth visits that turn those numbers into a protocol. OneTwenty launches in June 2026 with medications, the full legal-now formulary plus bioidentical HRT, and is positioned to carry the returning peptides across a network of compounding pharmacies the moment the July review clears them. At $499 a year for the membership, it is the most transparent and lowest-cost care layer in the category.
What stands out
- The complete legal-now core, where narrow clinics carry only one or two
- Quarterly comprehensive panels, not a one-off baseline draw
- Wearable, smart scale, and BP cuff data flowing in continuously
- AI health assistant that reads labs and device data together
- $499/yr flat, fully published, no surprise add-ons on the care layer
What is special
- The prescription follows the data, so dose titration is built into the model
- A pharmacy network rather than one partner means broader, more resilient supply at the reopening
- Peptides and bioidentical HRT in a single membership
- National telehealth with at-home lab draws at any nearby lab
Defy Medical
A Tampa-based concierge practice with nationwide telehealth and one of the deepest legitimate peptide practices in the country. Fellowship-trained medical directors lead physicians who specialize in interventional endocrinology and hormone restoration. Defy carries essentially the entire legal-now core and is the type of established practice that will resume the returning peptides quickly once they clear.
What stands out
- The full legal-now core, plus readiness on the returning list
- Fellowship-trained medical directors and physician-level prescribers
- Up to one-hour consultations with your prescriber
- In-person Tampa option plus nationwide telehealth
What is special
- A full spectrum of peptide and hormone protocols in a single relationship
- Access to treatments most insurance-based practices refuse to touch
- Evening and Saturday provider availability
Marek Health
Built its reputation on data. Standard panels test sixty-plus biomarkers, a full level deeper than almost any competitor, with a preventative rather than replacement-only philosophy. Strong on the legal-now core and positioned for the marquee returning peptides.
What stands out
- Sixty-plus biomarker panels, the deepest data in telehealth
- MD and DO prescribers with research-driven protocol design
- Monthly consultations built in
- HSA and FSA eligible
What is special
- A functional-medicine lens that catches issues hormone-only clinics miss
- Conversation shifts from basic education to genuine optimization
- Strong legal-now menu alongside comprehensive TRT
Victory Select
An online pharmacy and telehealth clinic based in Texas with one of the broadest specialty lists in the regional category, including the harder-to-find returning peptides like KPV and AOD-9604 alongside the standard recovery and growth hormone compounds.
What stands out
- The widest positioning on the returning list of any regional clinic
- Coverage of less common compounds most national clinics skip
- Online-pharmacy model simplifies dispensing
What is special
- Specialty breadth at typically lower pricing in covered states
- A natural home for the returning peptides once they clear
Maximus
Maximus is one of the best mainstream optimization clinics in the country: all fifty states, $199 a month flat with labs included, physician-led care, and a first-month-free promotion. But this is a peptide-specific ranking, and on peptides Maximus is sermorelin and nothing else. That is why a clinic this strong sits mid-pack here. If you want sermorelin with the easiest possible onboarding, it is still excellent.
What stands out
- All fifty states, which solves the geographic-restriction problem
- $199/mo flat with labs included
- At-home lab kits, no lab visits required
- First month free for new patients
What is special
- The smoothest sermorelin onboarding in the category
- Physician-designed protocol with before-and-after IGF-1 labs
- Community coaching built into the program
TRT Nation
Built around $99 a month flat-rate testosterone replacement with no contracts and unlimited consultations. The peptide story is thin: gonadorelin as TRT support now, and BPC-157 lined up for when it clears. A great TRT product, not a peptide clinic.
What stands out
- $99/mo flat-rate TRT, lowest serious price in category
- No contracts, cancel anytime
- Unlimited consultations at no extra cost
- Gonadorelin support and a BPC-157 plan
What is special
- The no-contract, unlimited-consult structure is genuinely rare
- Most affordable way to pair TRT with an eventual recovery peptide
- Home delivery of medications and supplies
Blue Sky MD
A North Carolina bioidentical hormone and peptide clinic with a telehealth arm for existing patients. The hybrid model, where you can combine in-person visits with telehealth follow-ups, is rare in a space that runs almost entirely over video.
What stands out
- Sermorelin now, plus a growth hormone stack lined up for the reopening
- In-person plus telehealth hybrid care
- Established North Carolina presence
What is special
- Walk into a physical clinic when an issue is harder to diagnose over video
- Long-standing local reputation and continuity of care
The OneTwenty formulary
The full menu, driven by your data.
OneTwenty launches in June 2026 with medications: the complete legal-now formulary plus bioidentical HRT, prescribed off comprehensive biomarker testing and quarterly panels. The returning peptides are listed exactly as they are, pending the July 2026 review, because honesty about the timeline is the whole point.
Available at launch
Legal today, June 2026
Rolling out after July 2026
Pending the FDA advisory review
The fine print
What is actually prescribable in 2026.
Three legal categories matter, and they get confused constantly.
FDA-approved peptide drugs
Standard prescription medications. Tesamorelin, PT-141 (bremelanotide), gonadorelin, and several others have full approval for specific indications and fill at any pharmacy. These are legal today.
Compounded peptides
Prepared by 503A pharmacies (patient-specific) or 503B outsourcing facilities (bulk, under FDA oversight) from bulk substances that are FDA-approved, carry a USP monograph, or sit in Category 1 of the 503A bulks list. Sermorelin, NAD+, and glutathione are available now. BPC-157, TB-500, CJC-1295, ipamorelin, and thymosin alpha-1 moved into Category 1 under evaluation in April 2026 and are pending the July 23 advisory review before compounding can resume.
Controlled-substance peptides
A separate framework. Synthetic human growth hormone (somatropin) is Schedule III with strict federal prescribing rules. That is distinct from the growth hormone-releasing peptides like sermorelin, ipamorelin, and CJC-1295, which prompt your pituitary to make its own GH. Legitimate therapy overwhelmingly uses secretagogues, not synthetic HGH.
Buyer’s guide
How to vet any peptide clinic.
Five things separate a legitimate telehealth clinic from a marginal one.
A named, licensed prescriber. You should see who writes your prescription and which state they are licensed in. A clinic that will not name its prescribers is hiding something.
A disclosed compounding pharmacy. The clinic should tell you which 503A or 503B pharmacy fills your script. State boards publish disciplinary records, so a quick check flags recent citations.
Honesty about the July 2026 timeline. Any clinic claiming it can dispense BPC-157, CJC-1295, or TB-500 today is either misinformed or cutting corners. Those are pending the advisory review. A straight answer about what is and is not legal yet is a trust signal.
Baseline and follow-up bloodwork. Add IGF-1 for growth hormone peptides and hs-CRP for long-term protocols, with re-checks at six to eight weeks, then every three to six months.
Cold-chain shipping. Many peptides are heat-sensitive. Shipments should arrive insulated with cold packs. Unlabeled vials or melted ice packs are reasons to push back.
Clear red flags: selling restricted peptides as available now, no prescription step, crypto-only payment, unmarked vials, "starting at" pricing that hides the real clinical-dose cost, or pressure to buy bundles before your first clinician call.
Research use only · not a recommended path
Looking for research peptides?
Research-chemical vendors sit outside the clinical framework this guide recommends. The FDA generally presumes peptides shipped to a home address are intended for human use regardless of labeling, so this route carries real legal and safety risk and includes no prescriber, bloodwork, or oversight. If you understand that and still want a reference vendor for laboratory research, here is one.
View research peptide sourceAffiliate link. We may earn a commission at no cost to you.
Getting started
Your first move.
Figure out what you are solving for first. Recovery and tissue repair, growth hormone support, longevity, or sexual health each point toward a different clinic on this list.
Bring recent bloodwork if you have it. Any legitimate clinic orders baseline labs, but results from the last six months can save a cycle and reduce upfront cost. Start with one clinic, not two, because running TRT from one provider and wellness peptides from another creates fragmented care and dangerous prescribing conflicts. And budget for ongoing monitoring, since most clinics do not include labs in the headline fee.
If you want the protocol built from the data rather than the data bolted onto a protocol, and you want to be first in line when the July reopening completes, that is the case for starting at the top of this list.
Stop Guessing Your Health
Live guidance for sleep, hormones, and weight powered by your wearables, devices + blood work.
Related Articles
Lifelong Optimization
Not your average
Checkup
Every life stage brings new biological demands. Tracking the right metrics at the right time helps you adapt, optimize performance, and extend both lifespan and healthspan.
Traditional
Manual Data Processing
Guesswork Trend Detection
Slow Campaign Setup
Multiple Tools, Multiple Logins
Reactive Decision-Making
Manual Reporting
Delayed Results
High Error Risk
Automated Data Sync
Real-Time Trend Insights
Instant AI Optimization
All-in-One Platform
Proactive AI-Driven Strategies
Auto-Generated Reports
Instant Performance Updates
AI Precision
Frequently Asked Questions
Clarity before
you commit
Answers on setup, scale, and support to remove blockers.
